unknown
Stage
1
Investors
About
CellChorus develops the TIMING platform, a technology that uses neural network-based microscopy to analyze thousands of single immune cells simultaneously, characterizing their migration, interactions, and functions to support cell therapy development and clinical research.
Explore CellChorus's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.